NYSE:ALR - Alere Stock Price, Price Target & More

Notice: This company has been marked as potentially delisted and may not be actively trading.
Sign in or create an account to add this stock to your watchlist.
$50.99 0.00 (0.00 %)
(As of 06/22/2018 04:00 PM ET)
Previous Close$50.99
Today's Range$50.99 - $50.99
52-Week Range$34.41 - $51.00
VolumeN/A
Average Volume1.53 million shs
Market Capitalization$4.47 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.21
Alere logoAlere Inc. is a provider of health information through diagnostic tests. The Company's segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The consumer diagnostics segment consists primarily of manufacturing operations related to its role as the exclusive manufacturer of products for SPD Swiss Precision Diagnostics (SPD), its joint venture with The Procter & Gamble Company (P&G). The Company's professional diagnostic solutions allow patients and their healthcare providers to work together to manage patients' conditions over the continuum of care, from the hospital to home. The Company offers lines of drugs-of-abuse tests, reagent systems and laboratory testing options.

Receive ALR News and Ratings via Email

Sign-up to receive the latest news and ratings for ALR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Supplies
SectorN/A
SymbolNYSE:ALR
CUSIP01449J10
Phone+1-781-6473900

Debt

Debt-to-Equity Ratio2.43
Current Ratio2.04
Quick Ratio1.54

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-16.86%
Return on Equity-33.39%
Return on Assets-6.72%

Miscellaneous

Employees9,700
Outstanding Shares87,580,000

Alere (NYSE:ALR) Frequently Asked Questions

What is Alere's stock symbol?

Alere trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALR."

How were Alere's earnings last quarter?

Alere Inc (NYSE:ALR) announced its quarterly earnings data on Friday, November, 4th. The medical research company reported $0.19 earnings per share for the quarter, missing analysts' consensus estimates of $0.54 by $0.35. The medical research company had revenue of $582 million for the quarter, compared to analysts' expectations of $605.50 million. Alere had a negative net margin of 16.86% and a negative return on equity of 33.39%. Alere's quarterly revenue was down 3.6% compared to the same quarter last year. During the same period last year, the firm earned ($0.10) earnings per share. View Alere's Earnings History.

What price target have analysts set for ALR?

1 Wall Street analysts have issued twelve-month target prices for Alere's shares. Their predictions range from $51.00 to $51.00. On average, they anticipate Alere's share price to reach $51.00 in the next year. View Analyst Ratings for Alere.

Who are Alere's key executives?

Alere's management team includes the folowing people:
  • Gregg J. Powers, Independent Chairman of the Board
  • Namal Nawana, President, Chief Executive Officer, Director
  • James F. Hinrichs, Chief Financial Officer, Executive Vice President
  • Daniella Cramp, Global President - Cardiometabolic Business Unit
  • Sanjay Malkani, Global President - Toxicology
  • Avi Pelossof, Global President - Infectious Disease Business Unit
  • Ellen Chiniara J.D., Senior Vice President, General Counsel, Chief Ethics and Compliance Officer, Secretary
  • Robert Hargadon, Senior Vice President - Global Human Resources
  • John Bridgen Ph.D., Senior Vice President - Business Development
  • Mark Gladwell, Senior Vice President - Global Operations

Has Alere been receiving favorable news coverage?

News headlines about ALR stock have trended somewhat positive recently, Accern reports. The research group ranks the sentiment of news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Alere earned a news impact score of 0.16 on Accern's scale. They also assigned media headlines about the medical research company an impact score of 46.75 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near term.

What is Alere's stock price today?

One share of ALR stock can currently be purchased for approximately $50.99.

How big of a company is Alere?

Alere has a market capitalization of $4.47 billion. Alere employs 9,700 workers across the globe.

How can I contact Alere?

Alere's mailing address is 51 Sawyer Rd Ste 200, WALTHAM, MA 02453-3448, United States. The medical research company can be reached via phone at +1-781-6473900.


MarketBeat Community Rating for Alere (ALR)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  311 (Vote Outperform)
Underperform Votes:  328 (Vote Underperform)
Total Votes:  639
MarketBeat's community ratings are surveys of what our community members think about Alere and other stocks. Vote "Outperform" if you believe ALR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.